Dr Line Melgaard MSc, PhD graduated from the University of Aalborg in 2013 with a master degree in Medicine with Industrial Specialization.
Dr Melgaard received a PhD-degree from Aalborg University in 2016 (title: “Thromboembolic risk in heart failure patients without atrial fibrillation”). During her PhD, she used Danish nationwide registry data to investigate predictors of ischemic stroke and thromboembolic events in a heart failure population without diagnosed atrial fibrillation.
Dr Melgaard is currently employed at the Thrombosis and Drug Research Unit, Department of Cardiology, Aalborg University Hospital in Denmark and her research interests include heart failure, atrial fibrillation, and thrombosis.
